Quantitation of autoantibodies to cytokeratins in sera from patients with squamous cell carcinoma of the oesophagus
1988

Autoantibodies to Cytokeratins in Oesophageal Cancer Patients

Sample size: 176 publication Evidence: moderate

Author Information

Author(s): R.B. Vealel, A.L. Thornley, E. Scott, A. Antoni, I. Sega

Primary Institution: University of the Witwatersrand and Baragwanath Hospital, South Africa

Hypothesis

Are raised levels of autoantibodies to cytokeratins associated with squamous cell carcinoma of the oesophagus?

Conclusion

The study found a significant increase in autoantibodies to certain cytokeratins in patients with oesophageal squamous cell carcinoma compared to healthy individuals.

Supporting Evidence

  • Patients with SCC showed a 32% increase in autoantibody titre when using SNO or HeLa cell extracts as antigens.
  • Immunofluorescence studies confirmed the presence of autoantibodies in 21 sera from patients with carcinoma.
  • Western blotting revealed that antibodies to cytokeratin 18 were present in most sera from SCC patients.

Takeaway

The study shows that people with a type of throat cancer have more antibodies against certain proteins than healthy people.

Methodology

Sera from healthy individuals, patients with SCC, and patients with mild active oesophagitis were compared using radioimmunoassay, immunoblotting, and immunofluorescence techniques.

Limitations

The study had a small sample size for patients with moderate oesophagitis and did not distinguish between adenocarcinoma and SCC.

Participant Demographics

All patients were black, aged 39-80, with a mean age of 57 years and a male/female ratio of 5.6:1.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication